Cargando…

Locoregional Extension Patterns of Nasopharyngeal Carcinoma Detected by FDG PET/MR

PURPOSE: We sought to define the locoregional extension patterns of nasopharyngeal carcinomas (NPCs) by positron emission tomography (PET)/magnetic resonance imaging (MRI) and to improve clinical target volume (CTV) delineation. METHODS: Between May 2017 and March 2021, 331 consecutive patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Caineng, Xu, Yuanfan, Huang, Shuang, Jiang, Feng, Jin, Ting, Jin, Qifeng, Hua, Yonghong, Hu, Qiaoying, Chen, Xiaozhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710458/ https://www.ncbi.nlm.nih.gov/pubmed/34966674 http://dx.doi.org/10.3389/fonc.2021.763114

Ejemplares similares

Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma
por: Zheng, Linfeng, et al.
Publicado: (2017)

Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Cao, Caineng, et al.
Publicado: (2019)

Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
por: Guo, Rui, et al.
Publicado: (2020)

Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Feng, Yanru, et al.
Publicado: (2019)

Grading of MRI–detected skull-base invasion in nasopharyngeal carcinoma with skull-base invasion after intensity-modulated radiotherapy
por: Feng, Yanru, et al.
Publicado: (2019)

Nutritional Status and Its Association With Radiation-Induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma During Radiotherapy: A Prospective Study
por: Shu, Zekai, et al.
Publicado: (2020)

Pediatric Nasopharyngeal Carcinoma as Seen on 18F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2019)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

Anti–PD-1 Monoclonal Antibody Combined With Anti-VEGF Agent Is Safe and Effective in Patients With Recurrent/Metastatic Head and Neck Squamous Cancer as Second-Line or Beyond Treatment
por: Hua, Yonghong, et al.
Publicado: (2022)

Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation
por: Li, Wen-Fei, et al.
Publicado: (2012)

The Diagnostic and Grading Accuracy of (68)Ga-DOTATATE and (18)F-FDG PET/MR for Pancreatic Neuroendocrine Neoplasms
por: Zhou, Jinxin, et al.
Publicado: (2022)

Colorectal cancer – patterns of locoregional recurrence and distant metastases as demonstrated by FDG PET / CT
por: Purandare, Nilendu C, et al.
Publicado: (2010)

Radiomics Analysis and Correlation With Metabolic Parameters in Nasopharyngeal Carcinoma Based on PET/MR Imaging
por: Feng, Qi, et al.
Publicado: (2020)

Diagnostic performance of zero-TE lung MR imaging in FDG PET/MRI for pulmonary malignancies
por: Zeng, Feibi, et al.
Publicado: (2020)

The Role of Pretreatment (18)F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yao, Jijin, et al.
Publicado: (2021)

M1 stage subdivisions based on (18)F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma
por: Qiu, Hui-Zhi, et al.
Publicado: (2022)

Induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis
por: Wang, Bi-Cheng, et al.
Publicado: (2022)

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: She, Longjiang, et al.
Publicado: (2022)

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma
por: Xiang, Xiaoyong, et al.
Publicado: (2023)

A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment
por: Wei, Ying-Hong, et al.
Publicado: (2022)

Prospective comparison of (68)Ga-FAPI-04 and (18)F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma
por: Ding, Haoyuan, et al.
Publicado: (2022)

Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma
por: Kulanthaivelu, Roshini, et al.
Publicado: (2022)

Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial
por: Huang, Xiaodong, et al.
Publicado: (2020)

PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer
por: Flygare, Lennart, et al.
Publicado: (2022)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
por: Choi, Horace Cheuk-Wai, et al.
Publicado: (2021)

Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zhang, Shan-Qiang, et al.
Publicado: (2022)

The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis
por: Liu, Mei, et al.
Publicado: (2018)

Induction chemotherapy with paclitaxel, carboplatin and cetuximab for locoregionally advanced nasopharyngeal carcinoma: A single-center, retrospective study
por: Takeshita, Naohiro, et al.
Publicado: (2022)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
por: O'Connor, Ellen, et al.
Publicado: (2020)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zou, Rui, et al.
Publicado: (2021)

Efficacy and Toxicity of Three Induction Chemotherapy Regimens in Locoregionally Advanced Nasopharyngeal Carcinoma: Outcomes of 10-Year Follow-Up
por: Peng, Hao, et al.
Publicado: (2021)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
por: Yan, Wenbin, et al.
Publicado: (2023)

Characteristics of locoregional extension of unilateral nasopharyngeal carcinoma and suggestions for clinical target volume delineation
por: Wu, Zheng, et al.
Publicado: (2022)

Risk stratification for nasopharyngeal carcinoma: a real-world study based on locoregional extension patterns and Epstein-Barr virus DNA load
por: Zhang, Lu-Lu, et al.
Publicado: (2020)

Prognostic Relevance of 18F-FDG-PET/CT-Guided Target Volume Delineation in Loco-Regionally Advanced Nasopharyngeal Carcinomas: A Comparative Study
por: Yan, Ouying, et al.
Publicado: (2021)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

An evaluation of nutrition intervention during radiation therapy in patients with locoregionally advanced nasopharyngeal carcinoma
por: Jin, Ting, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gf6a35gsbrqofvrd45e4ha8jnk